Nicholas Pennings
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicholas Pennings has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Harold Edward Bays
Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky, USA
3 shared publications - Angela Fitch
Knownwell
1 shared publication - Bernadette Riley
New York Institute of Technology College of Osteopathic medicine
1 shared publication - Catherine Varney
University of Virginia School of Medicine, USA
1 shared publication - Christopher D. Still
Geisinger Obesity Institute, Danville, PA, 17822, USA
1 shared publication - Deborah Bade Horn
Center for Obesity Medicine and Metabolic Performance, University of Texas McGovern Medical School, Houston, TX, USA
1 shared publication
Latest Publications
- Open Access
- 17 March 2025
- Published by Elsevier in Obesity Pillars
- Vol. 14, 100172
Obesity management in primary care: A joint clinical perspective and expert review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) - 2025
- 17 March 2025
- Published by Elsevier in Obesity Pillars
- Vol. 14, 100172
Open AccessObesity management in primary care: A joint clinical perspective and expert review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) - 2025
- Open Access
- 14 June 2024
- Published by Elsevier in Obesity Pillars
- Vol. 11, 100115
Neuropathy of diabetes following initiation of a low-carbohydrate diet: Case report
- 14 June 2024
- Published by Elsevier in Obesity Pillars
- Vol. 11, 100115
Open AccessNeuropathy of diabetes following initiation of a low-carbohydrate diet: Case report
- Open Access
- 12 April 2023
- Published by Elsevier in Obesity Pillars
- Vol. 6, 100062
Obesity medicine as a subspecialty and United States certification – A review
- 12 April 2023
- Published by Elsevier in Obesity Pillars
- Vol. 6, 100062
Open AccessObesity medicine as a subspecialty and United States certification – A review
- Open Access
- 16 November 2022
- Published by Elsevier in Obesity Pillars
- Vol. 4, 100043
Sleep-disordered breathing, sleep apnea, and other obesity-related sleep disorders: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
- 16 November 2022
- Published by Elsevier in Obesity Pillars
- Vol. 4, 100043
Open AccessSleep-disordered breathing, sleep apnea, and other obesity-related sleep disorders: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
- 15 March 2018
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 34 (4) , e2986
Ten‐year weight gain is associated with elevated fasting insulin levels and precedes glucose elevation
Background: Numerous studies have examined the relationship between endogenous insulin and weight change with mixed results. This study examined the relationship between fasting insulin levels, insulin resistance (IR), and 10‐year weight change by glycaemic stage.Methods: Using data from the US National Health and Nutrition Examination Survey 2011‐2014, 3840 participants were divided into 6 groups based on fasting glucose and fasting insulin levels. Fasting insulin concentrations were dichotomized into P < .0001). Across all groups, a 1 μU increase in fasting insulin levels resulted in a 0.52‐pound increase in weight (P < .0001). Similarly, an increase in HOMA‐IR was associated with increase in weight (1.32 lbs per IR unit, P < .0001). Marginal increases in weight were most pronounced in the normal insulin groups compared to elevated insulin groups and diminished as glycaemic stage progressed.Conclusions: Elevated fasting insulin level was positively associated with weight gain. The impact of fasting insulin and IR on weight gain preceded hyperglycaemia and diminished as glycaemic stage progressed.
- 15 March 2018
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 34 (4) , e2986
Ten‐year weight gain is associated with elevated fasting insulin levels and precedes glucose elevation
Background: Numerous studies have examined the relationship between endogenous insulin and weight change with mixed results. This study examined the relationship between fasting insulin levels, insulin resistance (IR), and 10‐year weight change by glycaemic stage.Methods: Using data from the US National Health and Nutrition Examination Survey 2011‐2014, 3840 participants were divided into 6 groups based on fasting glucose and fasting insulin levels. Fasting insulin concentrations were dichotomized into P < .0001). Across all groups, a 1 μU increase in fasting insulin levels resulted in a 0.52‐pound increase in weight (P < .0001). Similarly, an increase in HOMA‐IR was associated with increase in weight (1.32 lbs per IR unit, P < .0001). Marginal increases in weight were most pronounced in the normal insulin groups compared to elevated insulin groups and diminished as glycaemic stage progressed.Conclusions: Elevated fasting insulin level was positively associated with weight gain. The impact of fasting insulin and IR on weight gain preceded hyperglycaemia and diminished as glycaemic stage progressed.